Eugene Paschold

989 citations
12 papers · 615 · 1 hit paper · h-index 8

Impact in

  • Oncology top 10%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 2
    • Cancer Treatment and Pharmacology 1
    • Cancer therapeutics and mechanisms 2
    • Heat shock proteins research 1

Eugene Paschold

12 papers receiving 590 citations

Eugene Paschold's Hit Papers

Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099 2010 · 353 citations
3530+5+10Years since publication100200300

Peers

Eugene Paschold
Comparison fields: 5 of 61
  • Oncology 349
  • Pulmonary and Respiratory Medicine 298
  • Cancer Research 61
  • Genetics 20
  • Molecular Biology 126
Replace U. Brennscheidt with:
U. Brennscheidt Germany
John Stroehlein United States
E. Corgna Italy
Lambros Vamvakas Greece
Virginia Seery United States
Ioannis Xanthakis Greece
Sumio Noguchi Japan
Angela Sciandivasci Italy
Dengfeng Ren China
A. Reinacher-Schick Germany
Eugene Paschold relative to U. Brennscheidt Germany U. Brennscheidt's profile →
Citations per field
00.5×12×
U. Brennscheidt · 1×
Citations per year

Countries citing papers authored by Eugene Paschold

Since Specialization
Citations

This map shows the geographic impact of Eugene Paschold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Paschold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Paschold more than expected).

Fields of papers citing papers by Eugene Paschold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Paschold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Paschold. The network helps show where Eugene Paschold may publish in the future.

Co-authors

The 25 scholars most cited alongside Eugene Paschold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eugene Paschold Line = papers co-authored together Eugene Paschold links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099
Hit paper breakdown →
2010353
2 198863
3 201147
4 198640
5 201140
6 198438
7 200113
8
Megestrol acetate as primary hormonal therapy for advanced breast cancer.
198810
9
Operative technique for insertion of a totally implantable system for venous access.
19865
10 20123
11 20122
12 20191

About Eugene Paschold

Eugene Paschold is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 12 papers that have together received 615 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Lung Cancer Research Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer therapeutics and mechanisms (2 papers), Lung Cancer Treatments and Mutations (2 papers), Head and Neck Cancer Studies (1 paper), Heat shock proteins research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (349 citations), Pulmonary and Respiratory Medicine (298 citations), Cancer Research (61 citations), Genetics (20 citations) and Molecular Biology (126 citations). Eugene Paschold has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Thomas J. Lynch, Michael McCleod, Nicholas Iannotti, Shaker R. Dakhil, Martin R. Weber, Donald Woytowitz, Luke Dreisbach, Taral Patel, Robert C. Hermann and W. Heim. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Annals of Oncology, Cancer and The American Surgeon.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact